BETRFOTCPharmaceutical PreparationsFiscal year ends January 31
BetterLife Pharma Inc.
Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026
$0.15−0.01 (-3.71%)
Close on Oct 19, 2026
- Market cap
- $22.36M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns BetterLife Pharma's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RA Capital Management, L.P. | 55,420,000 | 9.00% | 13G (passive) | Sep 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ahmad Doroudian Chairman, Director | Sep 24, 2013 | Buy | +35,000,000 | – | – | 37,469,784 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.